v3.26.3
Concentrations
 9 Months Ended
Sep. 30, 2026
Concentrations [Abstract]  
CONCENTRATIONS

13. CONCENTRATIONS

 

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, other receivables and other non-current assets. The Company places its cash and cash equivalents with financial institutions with high-credit ratings in the U.S. The Company conducts credit evaluations of its customers and suppliers and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts.

 

The companies who accounted for 10% or more of the Company’s condensed consolidated accounts receivable and accounts payable as of December 31, 2025, and September 30, 2026, and of revenues and purchases for the nine months ended September 30, 2025 and 2026 were as follows.

 

    As of December 31,     As of September 30,  
    2025     2026  
Debtors   $     %     $     %  
Accounts receivable                        
Company A     775       27 %     *       *  
Accounts Payable                                
Company E     1,000       62 %     500       55 %

 

    For the nine months ended September 30,  
    2025     2026  
Debtors   $     %     $     %  
Revenues                        
Company A     324       14 %     1,521       22 %
Purchase                                
Company E     *       *       1,800       32 %

 

* Represents less than 10%